Saila Chadalavada

Saila Chadalavada serves as CEO at Alchemy Medicine. Alchemy Medicine operates in the pharmaceuticals sector with approximately 37.0 employees. The company is headquartered in Hyderabad, Telangana.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 338 executive contacts are available in Telangana.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 Mobile Friendly Bootstrap Framework Apache

generics antibacterials antifungals antivirals branded generics cardiovascular pharmaceutical manufacturing generic medicines branded otc products antibacterial antifungal gynae hormones nsaids pain relief antipyretic anti-allergic anti-emetics cough preparations anti-helminthic erectile dysfunction anti-malarial corticosteroids quality assurance usfda approved cgmp compliance affordable healthcare customer satisfaction drug research therapeutic segments supply chain management strategic product development flexible manufacturing biopharmaceuticals clinical trials quality assurance protocols innovative formulations sustainability in pharma market access regulatory compliance global distribution medical professionals healthcare partnerships therapeutic solutions over-the-counter medications oral tablets injectable solutions liquid formulations syrups suspensions powder for injection low-cost medication patient care trusted brands health improvement pharmaceuticals medical logistics & supply chain health care health wellness & fitness hospital & health care

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Saila Chadalavada in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Alchemy Medicine.

Saila Chadalavada's Position in the MessageCEO Database

• •Saila Chadalavada is 1 of 1 verified executive contact we track at Alchemy Medicine.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •338 verified executive contacts in Telangana are in the database.
• •5 verified contacts work at pharmaceuticals companies in the 37.0 employee range (same size as Alchemy Medicine).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated May 2026.

How do I reach Saila Chadalavada directly?

Saila Chadalavada's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Alchemy Medicine. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Saila Chadalavada work for?

Saila Chadalavada is CEO at Alchemy Medicine, a company in the pharmaceuticals sector with 37.0 employees. The company is based in Hyderabad, Telangana.

Can I pitch or sell to Saila Chadalavada?

As CEO at Alchemy Medicine, Saila Chadalavada is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Saila Chadalavada directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Saila Chadalavada in?

Saila Chadalavada works in the pharmaceuticals industry as CEO at Alchemy Medicine. MessageCEO provides verified contact information for executives across all major industries.

Is Saila Chadalavada's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Saila Chadalavada's profile is kept up-to-date with the latest available information.

Last updated: May 30, 2026